Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Renee Ridzon
In Global Health Research, Is It Legitimate to Stop Clinical Trials Early on Account of Their Opportunity Costs?
PLoS Medicine
Biochemistry
Biotechnology
Molecular Biology
Cell Biology
Medicine
Use of DNA Fingerprinting to Investigate a Multiyear, Multistate Tuberculosis Outbreak
Emerging Infectious Diseases
Epidemiology
Infectious Diseases
Microbiology
Related publications
Is It Legitimate and Beneficial for Judges to Compare?
Clinical Trials and International Health Research.
American Journal of Public Health
Environmental
Public Health
Occupational Health
Dengue Vaccine Clinical Trials in India — An Opportunity to Inform the Global Response to a Re-Emerging Disease Challenge
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Taking Opportunity Costs Seriously in Public Health Law
Public Health Reports
Environmental
Public Health
Occupational Health
Is It Time to Conduct Phase 3 Clinical Trials of Sex Hormones in MS – Commentary
Multiple Sclerosis
Neurology
When Is It Legitimate to Exclude Patients' Data From Study Results?
BMJ
Zika: Where It Has Been, Where It Is Going, and How to Stop It
International Journal of Clinical Practice
Medicine
Is It Time to Stop (Or Pause) Vertebral Augmentation?
Journal of Bone and Mineral Research
Endocrinology
Orthopedics
Sports Medicine
Metabolism
Diabetes
Clinical Trials in Developing Countries: Risk or Opportunity?
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology